Immunogenicity of Protein Therapeutics: A Lymph Node Perspective
The continuous development of molecular biology and protein engineering technologies enables the expansion of the breadth and complexity of protein therapeutics for in vivo administration. However, the immunogenicity and associated in vivo development of antibodies against therapeutics are a major r...
Main Authors: | Kristy Fu, Kylie March, Aikaterini Alexaki, Giulia Fabozzi, Eirini Moysi, Constantinos Petrovas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00791/full |
Similar Items
-
The dynamics of T and B cells in lymph node during chronic HIV infection: TFH and HIV, unhappy dance partners?
by: Jung Joo Hong, et al.
Published: (2016-11-01) -
The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses
by: Eirini Moysi, et al.
Published: (2018-08-01) -
Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells?
by: Antigoni Poultsidi, et al.
Published: (2018-09-01) -
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
by: Austin Negron, et al.
Published: (2020-12-01) -
Impact of chronic HIV/SIV infection on T follicular helper cell subsets and germinal center homeostasis
by: Stéphanie Graff-Dubois, et al.
Published: (2016-11-01)